Double-sided Entire Papilla Preservation (DEPP) technique was designed to allow access into a bone defect without compromising the integrity of papilla, when the defect extends to palatal/lingual side. This case-series study aimed to evaluate the clinical and radiographic outcomes of periodontal regenerative therapy using DEPP technique for intrabony defects. DEPP was performed with two vertical incisions on both the buccal and palatal sites to access the bone defect. After debridement, recombinant human fibroblast growth factor 2 or enamel matrix derivatives were used in combination with carbonate apatite (CO3Ap) or deproteinized bovine bone mineral (DBBM) to treat the defect. Periodontal parameters were evaluated at baseline, 6, and 12 months postoperatively. Values for clinical attachment level (CAL) and probing depth (PD) were statistically significantly improved compared with baseline at 6 months (P < 0.05) and 12 months (P < 0.01) following surgery. At 12 months, the mean PD reduction was 5.0 ± 1.4 mm and CAL gain was 5.3 ± 1.8 mm. According to the Composite Outcome Measure, the outcomes of the treated sites were considered 'successful'. This case series demonstrates that DEPP can be effectively combined with regenerative therapy for intrabony defects, yielding favorable clinical outcomes with minimal surgical complications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.11607/prd.7532 | DOI Listing |
J Am Coll Cardiol
March 2025
National Amyloidosis Centre, University College London, Royal Free Hospital, London, United Kingdom.
Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed chronic disease associated with progressive heart failure that results in impaired quality of life, repeated hospitalizations, and premature death. Acoramidis is a selective, oral transthyretin stabilizer recently approved by the U.S.
View Article and Find Full Text PDFTissue Cell
March 2025
Tissue Engineering and Regenerative Medicine Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic address:
Background: Cell therapy utilizing mesenchymal stem cells, which have the ability to differentiate into different lineages, has garnered significant attention in recent years. Melissa officinalis is rich in biologically active compounds and exhibits antioxidant activity, antimicrobial properties, and sedative effects. Nanoemulsions can facilitate the effective transfer of substances and also protect drugs and biological materials from environmental factors.
View Article and Find Full Text PDFEuropace
March 2025
Clinical Cardiac Academic Group, Genetic and Cardiovascular Sciences Institute, City-St George's University of London, London, UK.
Atrial fibrillation (AF) is one of the most common cardiac diseases and a complicating comorbidity for multiple associated diseases. Many clinical decisions regarding AF are currently based on the binary recognition of AF being present or absent with the categorical appraisal of AF as continued or intermittent. Assessment of AF in clinical trials is largely limited to the time to (first) detection of an AF episode.
View Article and Find Full Text PDFPLoS One
March 2025
Cell Biology-Inspired Tissue Engineering (cBITE), MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, The Netherlands.
Type 1 diabetic (T1D) patients are life-long dependent on insulin therapy to keep their blood glucose levels under control. An alternative cell-based therapy for exogenous insulin injections is clinical islet transplantation (CIT). Currently the widespread application of CIT is limited, due to risks associated with the life-long use of immunosuppressive drugs to prevent rejection of donor cells.
View Article and Find Full Text PDFInt Ophthalmol
March 2025
Burapha University Hospital, Burapha University, Saen Suk, Chonburi, Thailand.
Background: Retinitis pigmentosa (RP) is a retinal dystrophy and genetically heterogeneous group that causes vision loss and necessitates innovative therapeutic strategies, and mesenchymal stem cell (MSC) therapy has shown potential due to its regenerative and immunomodulatory properties. This meta-analysis aims to evaluate the efficacy and safety of MSC therapies in improving visual outcomes, focusing on the impact of various MSC types, administration methods, and duration of benefits.
Methods: A systematic search of peer-reviewed studies was conducted to identify clinical trials and observational studies investigating MSC therapies for retinal conditions.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!